PON1 and hepatocellular carcinoma: Finally, to assess whether resistin might be directly involved in the downregulation of PON1, we carried out in vitro experiments by using human hepatocellular carcinoma cells as a hepatocytes model, which are known to express PON1 and are thought to significantly contribute to the release of PON1 in the systemic circulation [29].